Company / Income Tax per Share
Theravance Biopharma, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.47
FY2025
5-year range
-$0.11 / $0.47
FY2021-FY2025
Trend
+92.3%
vs FY2024
Sector context
#32 of 201
Health Care
What the data says
Theravance Biopharma, Inc.'s income tax per share of $0.47 is higher than 84% of companies in the Health Care sector (FY2025). Income Tax per Share has increased for 3 consecutive years, from $-0.11 in FY2022 to $0.47 in FY2025.
Based on SEC 10-K filings.
0.47 in FY2025. Top quartile in the Health Care sector.
Increased from $0.09 to $0.47 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 201This company $0.47 Sector average $1.35
▼
-65.0% below sector average
Key checks
Key Insights
- Theravance Biopharma, Inc.'s income tax per share has grown for 3 consecutive years.
- In FY2025, income tax per share increased 92.3% year-over-year.
- Ranks #32 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | +92.3% |
| FY2024 | $0.25 | +170.3% |
| FY2023 | $0.09 | +179.3% |
| FY2022 | -$0.11 | -4776.2% |
| FY2021 | -$0.00 | +98.4% |
| FY2020 | -$0.15 | -160.8% |
| FY2019 | $0.25 | +32.3% |
| FY2018 | $0.19 | -28.3% |
| FY2017 | $0.26 | -2.6% |
| FY2016 | $0.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026